114 related articles for article (PubMed ID: 28626293)
1. CD146 Promoter Polymorphism (rs3923594) Is Associated with Recurrence of Clear Cell Renal Cell Carcinoma in Chinese Population.
Feng G; Huang HB; Ye XB; Zhang P; Huang JJ; Huang LZ; Cheng L; Pu C; Li G
Dis Markers; 2017; 2017():2543059. PubMed ID: 28626293
[TBL] [Abstract][Full Text] [Related]
2. CD146 gene expression in clear cell renal cell carcinoma: a potential marker for prediction of early recurrence after nephrectomy.
Feng G; Fang F; Liu C; Zhang F; Huang H; Pu C
Int Urol Nephrol; 2012 Dec; 44(6):1663-9. PubMed ID: 22826148
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.
Fisel P; Kruck S; Winter S; Bedke J; Hennenlotter J; Nies AT; Scharpf M; Fend F; Stenzl A; Schwab M; Schaeffeler E
Clin Cancer Res; 2013 Sep; 19(18):5170-81. PubMed ID: 23881922
[TBL] [Abstract][Full Text] [Related]
4. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
[TBL] [Abstract][Full Text] [Related]
5. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
Safarinejad MR; Shafiei N; Safarinejad S
Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma.
Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X
Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma.
Dufies M; Nollet M; Ambrosetti D; Traboulsi W; Viotti J; Borchiellini D; Grépin R; Parola J; Giuliano S; Helley-Russick D; Bensalah K; Ravaud A; Bernhard JC; Schiappa R; Bardin N; Dignat-George F; Rioux-Leclercq N; Oudard S; Négrier S; Ferrero JM; Chamorey E; Blot-Chabaud M; Pagès G
Theranostics; 2018; 8(9):2447-2458. PubMed ID: 29721091
[TBL] [Abstract][Full Text] [Related]
8. PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma.
Choi JW; Lee JH; Park HS; Kim YS
J Clin Pathol; 2011 Oct; 64(10):893-7. PubMed ID: 21725041
[TBL] [Abstract][Full Text] [Related]
9. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q
Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor binding protein-3 (IGFBP-3) gene variants are associated with renal cell carcinoma.
Safarinejad MR
BJU Int; 2011 Sep; 108(5):762-70. PubMed ID: 21314884
[TBL] [Abstract][Full Text] [Related]
11. Variants in angiogenesis-related genes and the risk of clear cell renal cell carcinoma.
Qin C; Chen J; Li J; Ju X; Zhang S; Cao Q; Han Z; Li P; Shao P; Wang M; Zhang Z; Gu M; Zhang W; Yin C
Mutagenesis; 2014 Nov; 29(6):419-25. PubMed ID: 25239121
[TBL] [Abstract][Full Text] [Related]
12. Glucose transporter polymorphisms are associated with clear-cell renal carcinoma.
Page T; Hodgkinson AD; Ollerenshaw M; Hammonds JC; Demaine AG
Cancer Genet Cytogenet; 2005 Dec; 163(2):151-5. PubMed ID: 16337858
[TBL] [Abstract][Full Text] [Related]
13. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
White-Al Habeeb NM; Di Meo A; Scorilas A; Rotondo F; Masui O; Seivwright A; Gabril M; Girgis AH; Jewett MA; Yousef GM
Clin Exp Metastasis; 2015 Aug; 32(6):531-41. PubMed ID: 26037892
[TBL] [Abstract][Full Text] [Related]
14. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
15. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
Kosari F; Parker AS; Kube DM; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Vasmatzis G
Clin Cancer Res; 2005 Jul; 11(14):5128-39. PubMed ID: 16033827
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.
Tupikowski K; Partyka A; Kolodziej A; Dembowski J; Debinski P; Halon A; Zdrojowy R; Frydecka I; Karabon L
Tissue Antigens; 2015 Nov; 86(5):353-61. PubMed ID: 26403483
[TBL] [Abstract][Full Text] [Related]
17. Association of ATG7 Polymorphisms and Clear Cell Renal Cell Carcinoma Risk.
Wang Z; Tao L; Xue Y; Xue L; Wang Z; Chong T
Curr Mol Med; 2019; 19(1):40-47. PubMed ID: 30827239
[TBL] [Abstract][Full Text] [Related]
18. Genetic association of polymorphisms in AXIN1 gene with clear cell renal cell carcinoma in a Chinese population.
Pu Y; Mi X; Chen P; Zhou B; Zhang P; Wang Y; Song Y; Zhang L
Biomark Med; 2017 Nov; 11(11):947-955. PubMed ID: 29053018
[TBL] [Abstract][Full Text] [Related]
19. Germline genetic variations in PDZD2 and ITPR2 genes are associated with clear cell renal cell carcinoma in Chinese population.
Zhang N; Wu Y; Gong J; Li K; Lin X; Chen H; Yu Y; Gou Y; Hou J; Jiang D; Na R; Wang X; Ding Q; Xu J
Oncotarget; 2017 Apr; 8(15):24196-24201. PubMed ID: 26918600
[TBL] [Abstract][Full Text] [Related]
20. Expression of miRNA-21 and miRNA-221 in clear cell renal cell carcinoma (ccRCC) and their possible role in the development of ccRCC.
Szabó Z; Szegedi K; Gombos K; Mahua C; Flaskó T; Harda K; Halmos G
Urol Oncol; 2016 Dec; 34(12):533.e21-533.e27. PubMed ID: 27427222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
